Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study.
Fiche publication
Date publication
octobre 2020
Journal
EClinicalMedicine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOLOGNA Serge, Dr DAGUINDAU Etienne, Dr DRENOU Bernard, Dr ROSSI Cédric
Tous les auteurs :
Lamure S, Duléry R, Di Blasi R, Chauchet A, Laureana C, Deau-Fischer B, Drenou B, Soussain C, Rossi C, Noël N, Choquet S, Bologna S, Joly B, Kohn M, Malak S, Fouquet G, Daguindau E, Bernard S, Thiéblemont C, Cartron G, Lacombe K, Besson C
Lien Pubmed
Résumé
Patients with lymphoma are immunocompromised because of the disease and its treatments. We aimed to describe the characteristics of patients with lymphoma hospitalized for Coronavirus Disease 2019 (Covid-19) and to analyze pre-Covid-19 determinants of mortality.
Référence
EClinicalMedicine. 2020 Oct 13;:100549